Search results
FTSE 100: GSK tops forecasts after strong sales of shingles vaccine
Yahoo Finance UK· 1 year agoGSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado...
Texas Pete isn’t plaintiff’s 1st class action lawsuit. Here’s how 3 others went
WDAF via Yahoo News· 9 months ago(WGHP) — The Texas Pete lawsuit isn’t California man Phillip White’s first rodeo. On Sept. 12,...
Shingles Vaccine Market is Booming in Near Future 2023-2031
NewMediaWire via Yahoo Finance· 1 year agoPune, India - (NewMediaWire) - March 3, 2023 - "Shingles Vaccine" Size, Scope, and Forecast...
Popular asthma inhaler will be discontinued Jan. 1. Here’s what users should know
Miami Herald via Yahoo News· 5 months agoPeople using the popular corticosteroid inhalers Flovent HFA or Flovent Diskus to treat their asthma...
12 Best Ethical Stocks To Buy Now
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we will take a look at 12 best ethical stocks to buy now. If you want to see some more of the best ethical stocks to buy, go directly to...
3 High Dividend Stocks With Attractive Total Return Potential
InvestorPlace via Yahoo Finance· 1 year agoIn the current economic climate of rising interest rates, persistent inflation, simmering...
GSK Key Drugs & Vaccines Help Stock Outperform Industry YTD
Zacks via Yahoo Finance· 6 months agoStrong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and...
Popular corticosteroid asthma inhaler Flovent was discontinued this month
Popular Science via Yahoo News· 5 months agoFlovent is a popular inhaled corticosteroid that helps keep inflammation in the lungs low and the...
GSK consumer spin-off Haleon floats in biggest London listing in a decade
Press Association News via AOL· 2 years agoGlaxoSmithKline’s consumer spin-off Haleon has floated on the London Stock Exchange in Europe’s...
Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 3 months agoRevenue: Innoviva Inc (NASDAQ:INVA) reported a 35% year-over-year increase in net product revenues...